Company Announcements

Director Declaration

Source: RNS
RNS Number : 1768V
Reckitt Benckiser Group PLC
04 April 2019
 

 

                                                                                                             4 April 2019

 

 

DIRECTORATE CHANGE: NICANDRO DURANTE

Appointment to Board of TIM Participações S.A.

 

In accordance with Listing Rule 9.6.14, Reckitt Benckiser Group plc announces that Nicandro Durante, Senior Independent Director, has been appointed as Chairman of TIM Participações S.A., a Brazil-based subsidiary of Telecom Italia, an Italian telecommunications company, with effect from 3 April 2019.

 

 

For further Information:
Rupert Bondy

Company Secretary

Tel +44 (0) 1753 217 800

 

Richard Joyce

SVP, Investor Relations

Tel. +44 (0)1753 217 800

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

 

About RB:

RB* is the global leading consumer health, hygiene and home company. Driven by a purpose of providing innovative solutions for healthier lives and happier homes, RB has operations in over 60 countries.  From the foundations of wellness and infant nutrition, to the fundamentals of a hygienic home, its global brands help people live healthier, happier lives.

RB has world leading Powerbrands which include household names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick.

RB's unique culture is at the heart of its success.  Its drive to achieve, passion to outperform and commitment to quality and scientific excellence is manifested in the work of over 40,000 employees worldwide. 

For more information visit www.rb.com 

 

*RB is the trading name of the Reckitt Benckiser group of companies

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RDNIIMBTMBJMBIL